Search research articles
Contact Us
Filters
Showing results (131-140 of 196) with videos related to
Page
of 20
Sort By:
Cell Cycle (Georgetown, Tex.)
|
June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide
Kei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas
Anthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 30, 2022
ASHP Foundation Pharmacy Forecast 2023: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems
Joseph T DiPiro, Todd W Nesbit, Charles Reuland, et al.
Journal of Cellular Biochemistry
|
February 9, 2017
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Anticancer Research
|
December 29, 2018
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein
Hiromichi Oshiro, Tasuku Kiyuna, Yasunori Tome, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Journal of the American Medical Informatics Association : JAMIA
|
March 13, 2021
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions
Patrick Wu, Scott D Nelson, Juan Zhao, et al.
Journal of Drug Targeting
|
July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Tissue & Cell
|
May 29, 2019
Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model
Hiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 196) with videos related to
Sort By:
Page
of 20
Cell Cycle (Georgetown, Tex.)
|
June 17, 2017
Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide
Kei Kawaguchi, Kentaro Igarashi, Takashi Murakami, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas
Anthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 30, 2022
ASHP Foundation Pharmacy Forecast 2023: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems
Joseph T DiPiro, Todd W Nesbit, Charles Reuland, et al.
Journal of Cellular Biochemistry
|
February 9, 2017
High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model
Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Anticancer Research
|
December 29, 2018
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein
Hiromichi Oshiro, Tasuku Kiyuna, Yasunori Tome, et al.
Oncotarget
|
September 15, 2017
Toxicology and efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice
Yong Zhang, Wenluo Cao, Makoto Toneri, et al.
Journal of the American Medical Informatics Association : JAMIA
|
March 13, 2021
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions
Patrick Wu, Scott D Nelson, Juan Zhao, et al.
Journal of Drug Targeting
|
July 20, 2018
Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models
Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, et al.
Oncotarget
|
November 22, 2017
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model
Kei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
Tissue & Cell
|
May 29, 2019
Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model
Hiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, et al.
Page
of 20